🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: low dose FDC placebo

Found 14 matching trials

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

PHASE3

This is a study to evaluate the effect on LDL-C and the safety and tolerabi...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-08-17

Trial ID

NCT07619131

Treatments Being Tested

Laroprovstat Rosuvastatin 1 Rosuvastatin 2 Laroprovstat/Rosuvastatin 1 Placebo to match rosuvastatin Placebo to match Laroprovstat and Laroprovstat/Rosuvastatin 1 Laroprovstat/Rosuvastatin 2 Placebo to match Laroprovstat/Rosuvastatin 2

Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

PHASE3

The objective of this study is to assess the efficacy and safety of 12 week...

Status

Completed

Location

1237.26.10620 Boehringer Ingelheim Investigational Site

Start Date

2013-11

Trial ID

NCT02006732

Treatments Being Tested

olodaterol tiotropium placebo

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

The purpose of this Phase III study is to evaluate the long-term safety and...

Status

Completed

Location

Forest Investigative Site 1827

Start Date

2012-04

Trial ID

NCT01572792

Treatments Being Tested

Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)Aclidinium bromide Formoterol Fumarate Placebo

Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients

PHASE3

The objective of the trial is to compare the lung function profile of once ...

Status

Completed

Location

1237.11.32002 Boehringer Ingelheim Investigational Site

Start Date

2013-10

Trial ID

NCT01969721

Treatments Being Tested

fluticasone propionate salmeterol placebo placebo tiotropium olodaterol olodaterol placebo placebo tiotropium fluticasone propionate salmeterol

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

PHASE3

The primary objective of this trial is to investigate the effect of 6 weeks...

Status

Completed

Location

1237.14.01404 Boehringer Ingelheim Investigational Site

Start Date

2012-02

Trial ID

NCT01533935

Treatments Being Tested

Placebo Tiotropium + Olodaterol tiotropium + Olodaterol Tiotropium Olodaterol Respimat

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

PHASE3

The purpose of this study is to evaluate the effect on low-density lipoprot...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-09-15

Trial ID

NCT07619118

Treatments Being Tested

laroprovstat/rosuvastatin 1 laroprovstat/rosuvastatin 2 laroprovstat/rosuvastatin 3 laroprovstat/rosuvastatin 4 Placebo to match laroprovstat/rosuvastatin 1,2,3 Placebo to match laroprovstat/rosuvastatin 4 Rosuvastatin 1 Rosuvastatin 2 Rosuvastatin 3 Rosuvastatin 4 Placebo to match Rosuvastatin

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

PHASE3

This study is researching an experimental drug called REGN3767, also known ...

Status

Active Not Recruiting

Location

UC San Diego

Start Date

2023-01-16

Trial ID

NCT05608291

Treatments Being Tested

Fianlimab Cemiplimab Pembrolizumab Placebo

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

PHASE3

The primary objective of this trial is to investigate the effect of 6 weeks...

Status

Completed

Location

1237.13.01302 Boehringer Ingelheim Investigational Site

Start Date

2012-03

Trial ID

NCT01533922

Treatments Being Tested

Placebo Tiotropium Olodaterol tiotropium + olodaterol Tiotropium + Olodaterol Respimat

Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy

PHASE2

The goal of this clinical trial is to compare the safety and efficacy of ef...

Status

Terminated

Location

The Oncology Institute

Start Date

2023-05-22

Trial ID

NCT05747794

Treatments Being Tested

eftilagimod alpha Paclitaxel placebo

Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease

PHASE3

The primary objective of the trial is to determine the 24-hour FEV1-time pr...

Status

Completed

Location

1237.20.1204 Boehringer Ingelheim Investigational Site

Start Date

2012-03

Trial ID

NCT01559116

Treatments Being Tested

tiotropium + olodaterol tiotropium olodaterol tiotropium tiotropium + olodaterol Placebo Respimat

Previous Next